BOSTON and BERLIN, Dec. 29, 2017 -- ZAGENO Inc., the fast-growing digital marketplace for research materials, has developed an impressive portfolio, making it the first choice for purchasing and comparing lab materials online. Since late 2015, ZAGENO has been growing its biotech product portfolio to not only include trending life science techniques, but to also accommodate widely used scientific methods and experimental processes.
Successful Combination of Biotechnology and E-Commerce
ZAGENO has rapidly developed into the largest online marketplace for life science research kits and reagents. From a few thousand products, with primarily major brands, ZAGENO grew into a one-stop shop for more than 1.4 million biotechnology products, belonging to more than a thousand different biotechnology brands.
In under two years, not only has a state-of-the-art e-commerce platform been developed, but also an innovative way of sorting and categorizing research products has evolved. From an initial six categories, with 29 subcategories, the platform now holds 7 categories, 100+ subcategories and within them, more than 1.4 million products. This number increases by thousands of products each day, thanks to our specialized content team.
Made for Pioneering Life Science Researchers
By keeping up with trending life science techniques and adding crucial reagents for experiments, e.g., CRISPR kits or sequencing chips to its portfolio, ZAGENO utilizes its online marketplace to keep its customers at the forefront of biotech research. In just under 12 months, due to customer demand, ZAGENO increased its product portfolio ten-fold.
The most significant addition is a comprehensive antibody catalog, including major brands such as VWR International, as well as up-and-coming brands like ProteoGenix.
Portfolio Extension: Customized Research Products and Lab Instruments
In the next six months, the platform will see another major increase from 1.4 Million SKUs to more than four Million SKUs, which marks another milestone in the history of the young company. ZAGENO will also look to extend further into customized research products, while also expanding the portfolio to lab instruments, analytical research apparatus, and other promising categories. Furthermore, the marketplace categorization and e-commerce framework are advancing to adopt crucial, as well as trending, topics in life science research, while accommodating the convenience of modern online shopping.
Boilerplate:
About ZAGENO Inc.
Since its formation in 2015, ZAGENO Inc. has set new standards in the international biotech market. With the vision to offer an online marketplace connecting scientists, academic research institutes, and biotech manufacturers, ZAGENO grows exponentially and represents a milestone for the digitization of science and research. World-renowned research facilities use ZAGENO for ordering lab equipment and for optimizing internal processes. The start-up employs 47 staff members in Boston (USA) and Berlin (Germany). These two locations were selected to be close to centers known for research advancements and scientific breakthroughs. For more “EUREKA”-moments – welcome to ZAGENO: https://zageno.com/
Company Contact:
Gesa Schramme,
Vice President Digital Growth
ZAGENO Inc.
[email protected]
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5d50b481-cc9a-436a-ad10-e236400f5b46


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 



